The association of psychosocial screening and service provision in pediatric oncology: the Psychosocial Assessment Tool (PAT2.0) into clinical practice
Distress screening in oncology has been widely endorsed in recent years. However, current knowledge of the impact of screening on delivery of clinical psychosocial services is limited. This study investigated the association between screening and psychosocial services in the early period following diagnosis of childhood cancer.
The Psychosocial Assessment Tool (PAT2.0) was administered by clinical social workers in two pediatric oncology centers shortly following diagnosis. Psychosocial service activity in the first 8 weeks post diagnosis was collected via social work surveys and extraction of information from hospital databases.
PAT2.0 and psychosocial service data were obtained for 89 families with a child newly diagnosed with cancer. Distribution of PAT2.0 risk categories was consistent with previous studies (57.3 % universal, 38.2 % targeted, 4.5 % clinical). Significant, weak to moderate correlations between PAT2.0 and social workers’ estimates of psychosocial risk were observed. No significant differences in the amount of psychosocial services provided to families with “universal” versus “elevated” (i.e., targeted or clinical) risk were found. Number of days in hospital was strongly and positively associated with the amount of psychosocial services families received in the first 8 weeks following diagnosis.
Psychosocial risk, as measured by the PAT2.0, and allocation of psychosocial services were not significantly associated in the early period following diagnosis. Further investigation is required to understand if differences emerge over time when psychosocial screening is implemented clinically. Development of clinical pathways of care needs to account for patients who may predominantly be treated in the outpatient setting.
KeywordsScreening Pediatric oncology Distress Psychosocial Childhood cancer
- 2.Lazenby M (2014) The international endorsement of US distress screening and psychosocial Guidelines in oncology: a model for dissemination. J Natl Compr Cancer Netw 221–227Google Scholar
- 5.Comission for Cancer (2012) Cancer program standards 2012: ensuring patient centred care, V1.0. American College of Surgeons, ChicagoGoogle Scholar
- 7.Pai AL, Patino-Fernandez AM, McSherry M, Beele D, Alderfer MA, Reilly AT, Hwang WT, Kazak AE (2008) The Psychosocial Assessment Tool (PAT2.0): psychometric properties of a screener for psychosocial distress in families of children newly diagnosed with cancer. J Pediatr Psychol 33(1):50–62. doi:10.1093/jpepsy/jsm053
- 11.Barrera M, Hancock K, Rokeach A, Cataudella D, Atenafu E, Johnston D, Punnett A, Nathan PC, Bartels U, Silva M, Cassidy M, Jansen P, Shama W, Greenberg C (2014) External validity and reliability of the Psychosocial Assessment Tool (PAT) among Canadian parents of children newly diagnosed with cancer. Pediatr Blood Cancer 61(1):165–170. doi:10.1002/pbc.24774 CrossRefPubMedGoogle Scholar
- 12.Alderfer MA, Mougianis I, Barakat LP, Beele D, DiTaranto S, Hwang WT, Reilly AT, Kazak AE (2009) Family psychosocial risk, distress, and service utilization in pediatric cancer: predictive validity of the Psychosocial Assessment Tool. Cancer 115(18 Suppl):4339–4349. doi:10.1002/cncr.24587 CrossRefPubMedGoogle Scholar
- 14.Barrera M, Hancock K, Rokeach A, Atenafu E, Cataudella D, Punnett A, Johnston D, Cassidy M, Zelcer S, Silva M, Jansen P, Bartels U, Nathan P, Greenbery C (2014) Does the use of the revised Psychosocial Assessment Tool (PATrev) result in improved quality of life and reduced psychosocial risk in Canadian families with a child newly diagnosed with cancer? Psycho-Oncology 23(2):165–172. doi:10.1002/pon.3386 CrossRefPubMedGoogle Scholar
- 18.Pai AL, Tackett A, Hente E, Ernest M, Denson L, Hommel K (2014) Assessing psychosocial risk in pediatric inflammatory bowel disease: validation of the Psychosocial Assessment Tool 2.0_general. J Pediatr Gastroentrerol Nutr 58(1):51–56. doi:10.1097/MPG.0b013e3182a938b7